Hans C. Lee, Naresh Bumma, Joshua Ryan Richter, Jeffrey A. Zonder, James E. Hoffman, Zheng-Yi Zhou, Viviana Garcia Horton, Mirko Fillbrunn, Hongjue Wang, Matthew Mattera, Wenxin Ma, Timothy Inocencio, Yingxin Xu, James Harnett, Tito Roccia, Kate Knorr, Glenn Scott Kroog, Karen Rodriguez Lorenc, Qiufei Ma, Sundar Jagannath. "Comparative efficacy of linvoseltamab versus teclistamab in triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM): Updated matching-adjusted indirect comparison (MAIC) with longer follow-up.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7526